Envveno MedicalNVNO
13F holders, Q2 2024 (June 30)26holders −6
3new positions
8sold out
1famous investor
$5.25avg. 13F price*
At the end of Q2 2024, 26 institutions reported holding Envveno Medical Corporation (NVNO) in their 13F filings, down 6 from Q1 2024. 3 opened new positions and 8 sold out. The largest holders were Kingdon Capital Management, L.L.C. ($3.4M), Perceptive Advisors LLC ($3.3M) and Vanguard Group Inc. ($3.1M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Envveno Medical Corporation
- CUSIP
- 29415J106
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $77K |
| Exits | 8 | $1.8M |
All 13F filers, Q1 2024 → Q2 2024: 94,739 shares bought and 405,570 shares sold, net −310,831 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Kingdon Capital Management, L.L.C. | 0.53% | No change | 653,870 | $3.4M |
| Perceptive Advisors LLC | 0.08% | No change | 623,315 | $3.3M |
| Vanguard Group Inc. | 0.00% | Add +2.6% | 589,141 | $3.1M |
| Nantahala Capital Management, LLC | 0.25% | Reduce -3.6% | 477,855 | $2.5M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.04% | Add +2.0% | 230,790 | $1.2M |
| ADAR1 Capital Management, LLC | 0.21% | No change | 201,728 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Add +1.7% | 139,774 | $734K |
| Morgan Stanley | 0.00% | Reduce -2.7% | 94,873 | $498K |
| BlackRock Inc. | 0.00% | Add +5.3% | 39,469 | $207K |
| Westside Investment Management, Inc. | 0.05% | Add +933.6% | 38,762 | $204K |
| Northern Trust Corp. | 0.00% | Reduce -2.5% | 34,270 | $180K |
| Laird Norton Wetherby Trust Company, LLC | 0.02% | No change | 33,000 | $173K |
| Fermata Advisors, LLC | 0.04% | Add +33.4% | 30,949 | $162K |
| State Street Corp. | 0.00% | Add +7.7% | 26,500 | $139K |
| UBS Group AG | 0.00% | Add +202.3% | 16,800 | $88K |
| Dimensional Fund Advisors LP | 0.00% | No change | 16,411 | $86K |
| Arthur M. Cohen & Associates, LLC | 0.01% | New | 14,000 | $74K |
| Tamar Securities, LLC | 0.01% | No change | 13,990 | $73K |
| Citadel Advisors | 0.00% | Reduce -84.3% | 7,145 | $38K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -31.5% | 2,388 | $13K |
| Wells Fargo & Company | 0.00% | Reduce -4.5% | 2,000 | $11K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 860 | $4K |
| Osaic Holdings, Inc. | 0.00% | Reduce -94.7% | 600 | $3K |
| Simplex Trading, LLC | 0.00% | New | 667 | $3K |
| Royal Bank of Canada | 0.00% | Add +945.5% | 115 | $1K |
| Bank of America Corp. | 0.00% | New | 99 | $520 |
"% of holder's portfolio" is NVNO's weight in each manager's 13F, not the share of Envveno Medical Corporation the manager owns.